Tumorigenicity assessment of cell therapy products: The need for global consensus and points to considerYoji Sato, Jan Willem van der Laan, Carla Herberts et al.|Cytotherapy|2019Cited by 166
Safety of cell therapy products: in-vitro methods to assess the tumorigenicity of human cell-based therapeutic productsHideaki Bando, Jan van der Laan, Matteo Piazza et al.|Cytotherapy|2020Cited by 3